This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Non-steroidal anti-inflammatory drugs in palliative care

Authoring team

Indications as analgesics in palliative care, including action as adjuvant analgesic:

  • bone pain
  • soft tissue pain due to malignant infiltration
  • arthritis
  • possible role in early management of neuropathic pain

Assess analgesic response after regular use for one week.

Patients considered to be at risk of NSAID induced gastroduodenal ulceration (age over 65 years, past history of PUD, concomitant oral steroids or anticoagulants, serious comorbidity) should receive a gastroprotective drug such as a proton pump inhibitor.

Extreme caution in renal failure. Fluid retention and renal function may all be worsened by NSAIDs.

NSAIDs may be considered for asthmatic patients unless they have a history of aspirin sensitivity.

Reference:

  1. West Midlands Palliative Care Physicians (2007). Palliative care - guidelines for the use of drugs in symptom control.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.